Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies. 

Biotechnology

Education

Genesis Therapeutics

Genesis Therapeutics' headquarters in South San Francisco, CA, United States

Evan Feinberg

Christopher Burke

Alla Ivanova

Senior Manager, Program And Alliance Management

Maruan Al-Shedivat

Principal QM Research Scientist / Engineer

Luis Landgrave

Louie Naumovski

Indrawan McAlpine

Peppi Prasit

Will McCarthy

James Schaeffer

Leonard Bell

Description

People (8)

James (Korrawat) Pruegsanusak

Alexander Izvorski

Irene Hyo

Carl Tilbury

Vyom Thakkar

Daniel Zeng

Nico Greenarry

Jennifer Bodily

Jobs